As the world of DNA sequencing becomes more efficient and less expensive, a number of companies are sprouting up within the space. The latest, Phosphorus, has just raised a $10 million Series A led by FirstMark.
Phosphorus is actually a spin-out from a previous genomics company called Recombine, which sold to CooperSurgical last year in a transaction valued at $85 million.
Recombine, led by… Read More...